Evaluation and management of attention-deficit hyperactivity disorder

American Family Physician

Volumn 55, Issue 3, 1997, Pages 887-901

  Taylor, Michael A ^a  

^a UNIVERSITY OF ALABAMA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACADEMIC ACHIEVEMENT; ATTENTION DEFICIT DISORDER; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC APPROACH ROUTE; DRUG CONTRAINDICATION; GENERAL PRACTITIONER; MEDICAL EDUCATION; MENTAL HEALTH SERVICE; REVIEW; TREATMENT PLANNING;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; CHILD, PRESCHOOL; HUMANS;

EID: 0031043403     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (19)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, D.C.: American Psychiatric Association, 1994;78-85.
2. Barkley RA. Attention-deficit hyperactivity disorder: a handbook for diagnosis and treatment. New York: Guilford Press, 1990;61-2,95-105,278,324.
3. Goldstein S, Goldstein M. Managing attention disorders in children: a guide for practitioners. New York: Wiley, 1990;37,72-123,221,226.
4. Recommendations for preventive pediatric health care. Committee on Practice and Ambulatory Medicine. Pediatrics 1995;96(2 Pt 1):373-4.
5. Coleman WS. Attention deficit disorders, hyperactivity, and associated disorders: a handbook for parents and professionals. 6th ed. Madison, Wis.: Calliope, 1993;5-30.
6. Pelham WE, Murphy HA. Attention deficit and conduct disorders. In: Hersen M, ed. Pharmacological and behavioral treatment: an integrative approach. New York: Wiley, 1986:108-48.
7. Weiss G, Hechtman LT. Hyperactive children grown up: ADHD in children, adolescents, and adults. 2d ed. New York: Guilford Press, 1993.
8. Elia J, Borcherding BG, Rapoport JL, Keysor CS. Methylphenidate and dextroamphetamine treatments of hyperactivity: are there true nonresponders? Psychiatry Res 1991;36:141-55.
9. American Academy of Pediatrics Committee on Children with Disabilities, Committee on Drugs: medication for children with an attention deficit disorder. Pediatrics 1987;80:758-60.
10. Gadow KD, Sverd J. Stimulants for ADHD in child patients with Tourette's syndrome: the issue of relative risk. J Dev Behav Pediatr 1990;11:269-71.
11. Gittelman R, Mannuzza S, Shenker R, Bonagura N. Hyperactive boys almost grown up. I. Psychiatric status. Arch Gen Psychiatry 1985;42:937-47.
12. Hechtman L. Adolescent outcome of hyperactive children treated with stimulants in childhood: a review. Psychopharmacol Bull 1985;21:178-91.
13. Brown RT, Wynne ME, Slimmer LW. Attention deficit disorder and the effect of methylphenidate on attention, behavioral, and cardiovascular functioning. J Clin Psychiatry 1984;45:473-6.
14. Feldman H, Crumrine P, Handen BL, Alvin R, Teodori J. Methylphenidate in children with seizures and attention-deficit disorder. Am J Dis Child 1989;143:1081-6.
15. Ciba Pharmaceuticals. Ritalin package insert. In: Physician's desk reference. 50th ed. Montvale, N.J.: Medical Economics, 1996.
16. SmithKline Beecham. Dexedrine package insert. In: Physician's desk reference. 50th ed. Montvale, N.J.: Medical Economics, 1996.
17. Abbott Laboratories. Desoxyn package insert. In: Physician's desk reference. 50th ed. Montvale, N.J.: Medical Economics, 1996.
18. Abbott Laboratories. Cylert package insert. In: Physician's desk reference. 50th ed. Montvale, N.J.: Medical Economics, 1996.
19. Fargason RE, Ford CV. Attention deficit hyperactivity disorder in adults: diagnosis, treatment, and prognosis. South Med J 1994;87:302-9.